US Patent Issued to Abbott Diabetes Care on March 31 for "Artificial pancreas integrated CGM architectures and designs" (California Inventors)

ALEXANDRIA, Va., March 31 -- United States Patent no. 12,589,204, issued on March 31, was assigned to Abbott Diabetes Care Inc. (Alameda, Calif.).

"Artificial pancreas integrated CGM architectures and designs" was invented by Gary Alan Hayter (Oakland, Calif.) and Erwin Satrya Budiman (Fremont, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "A system for managing a patient's glucose level includes a glucose sensor to generate and store data signals for measurements of the patient's glucose level made by the glucose sensor; an insulin pump; and sensor electronics operatively coupled to the glucose sensor, the sensor electronics comprising a memory storing one or more predetermined characteristics associ...